تحميل...
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
TP53 is the most frequently mutated or deleted gene in triple negative breast cancer (TNBC). Both the loss of TP53 and the lack of targeted therapy are significantly correlated with poor clinical outcomes, making TNBC the only type of breast cancer that has no approved targeted therapies. Through in...
محفوظ في:
| الحاوية / القاعدة: | Nat Nanotechnol |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2019
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6449187/ https://ncbi.nlm.nih.gov/pubmed/30804480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41565-019-0381-6 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|